Home | News | CNIO Friends | CNIO and La Roche-Posay sign collaboration agreement

CNIO and La Roche-Posay sign collaboration agreement

14.01.2019

Help us to stop cancer

therapies

The money given by the cosmetics firm will go to the 'CNIO Friends' project, whose aim is to raise awareness of the importance of cancer research and attract supporters to the CNIO

The #InvestigaciónEsVida project

In 2019, La Roche-Posay will support CNIO-led projects. The money will go to CNIO Friends, a project aimed at attracting supporters of cancer research that has enabled CNIO to start new lines of research in child cancer, pancreatic cancer and the use of nanotechnology in cancer treatment, among others. The #InvestigaciónEsVida project is framed within L’Oréal Group’s Sharing Beauty With All programme, consisting of a series of goals commited with sustainability to be achieved by 2020. “We are really happy to help cancer patients improve their quality of life through the support to a renowned institute as the CNIO. At the CNIO, they do pioneering work on life-saving cancer treatments,” said Patricia Sarasúa, General Manager at La Roche-Posay Spain.

In the words of CNIO Director Maria A. Blasco, “getting continuous support is very important to us at CNIO. We have individual and corporate supporters that are helping us attract talented scientists and start or develop ground-breaking cancer research lines. We are really proud to have La Roche-Posay and L’Oréal Group with us, as they can help us make progress by supporting the valuable work of CNIO researchers.”

About the ‘CNIO Friends’ project

CNIO is a Spanish public institute specialising in cancer research, diagnosis and treatment considered to be among the best of its kind in the world for both its numerous scientific findings and its development of innovative treatments. CNIO covers the entire spectrum of R&D activities, from basic research to clinical trials, transferring knowledge to the National Health System and the pharmaceutical and biotechnology industry in fast, effective ways. Nearly 400 scientists work at CNIO, studying the most common types of cancer as well as rare tumours and metastatic cancer. In addition, CNIO carries out a drug development programme and a clinical research programme run by oncologists working in Spanish hospitals. CNIO also conducts clinical trials and offers genetic diagnostic and consulting services to thousands of families.

In 2014, CNIO launched CNIO Friends, an initiative whose goal is to attract supporters of oncology research. The more than 1000 participants in the CNIO Friends project have a real impact on cancer research. A Postdoctoral Contract CNIO Friends Programme has been established to engage young scientists from all over the world, who have to go through a strict hiring process. People interested in donating to ground-breaking oncology research can visit https://www.cnio.es/en/cnio-friend/.

About La Roche-Posay’s #InYourSkin oncology project

Since 2009, numerous oncological patients with dermatological problems began to visit the thermal center of La Roche-Posay and, since 2013, La Roche-Posay has been investigating the cutaneous effects of oncological treatments. For this reason, the brand created Seskimo Group, a group of experts led by dermatologists and oncologists specializing in cancer therapies and adverse effects of the skin. Seskimo Group has identified the cosmetic needs of cancer patients and has created a protocol with recommendations for cosmetic care and makeup perfectly adapted to the patient’s needs during treatment.

One of the initiatives supported by La Roche-Posay to help people with cancer is the Skincare Units, run in hospitals and clinics throughout the country. In these workshops, patients can learn how to take care of their skin before, during and after cancer treatment from healthcare professionals and volunteers.

Back to the news

Up